Therapeutic advances in endocrinology and metabolism

Keyphrases

Publications

volume 15, 2024

Ana María Gómez Medina, Camilo A González, Oscar M Muñoz, Yalinne Gómez, Pablo E Jaramillo, Diana Henao, Luis M Rodríguez, Yurany Molina
HbA1c overestimates the glucose management indicator: a pilot study in patients with diabetes, chronic kidney disease not on dialysis, and anemia using isCGM. Therapeutic advances in endocrinology and metabolism 15 (2024)
Sindhoora Kotha, Sven Plein, John P Greenwood, Eylem Levelt
Role of epicardial adipose tissue in diabetic cardiomyopathy through the lens of cardiovascular magnetic resonance imaging - a narrative review. Therapeutic advances in endocrinology and metabolism 15 (2024)
Larissa Fabre, Érika Bevillaqua Rangel
Age-related markers and predictors of diabetic kidney disease progression in type 2 diabetes patients: a retrospective cohort study. Therapeutic advances in endocrinology and metabolism 15 (2024)
Clifford J Bailey
Diabetes and gout: another role for SGLT2 inhibitors? Therapeutic advances in endocrinology and metabolism 15 (2024)
Saleh Hadi Alharbi
Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications. Therapeutic advances in endocrinology and metabolism 15 (2024)
Sharmaine Thirunavukarasu, Mehak Asad, Sindhoora Kotha, Henry Procter, Marilena Giannoudi, Hui Xue, Peter Kellman, John P Greenwood, Eylem Levelt
Remote myocardial zone characteristics in type 2 diabetes patients with prior myocardial infarction and comparisons with diabetes patients with no prior infarction. Therapeutic advances in endocrinology and metabolism 15 (2024)
Harold Henrison Chang Chiu, Jun-Sing Wang
Potential of duodenal mucosal resurfacing in achieving glycemic control in Asians with type 2 diabetes. Therapeutic advances in endocrinology and metabolism 15 (2024)
Waleed Alghamdi, Mahmoud Mosli, Saleh A Alqahthani
Gut microbiota in MAFLD: therapeutic and diagnostic implications. Therapeutic advances in endocrinology and metabolism 15 (2024)
Ritah Kiconco, Sylvia Achieng Lumumba, Charles Nkubi Bagenda, Raymond Atwine, Joseph Ndarubweine, Simon Peter Rugera
Insulin therapy among diabetic patients in rural communities of Sub-Saharan Africa: a perspective review. Therapeutic advances in endocrinology and metabolism 15 (2024)
Consolato Maria Sergi, Mohit Kehar, Carolina Jimenez-Rivera
Liver Biopsy Handling of Metabolic-Associated Fatty Liver Disease (MAFLD): the Children's Hospital of Eastern Ontario grossing protocol. Therapeutic advances in endocrinology and metabolism 15 (2024)
Carol Wong, Anne De Bray, Naeem Ul Hassan, Ahmed Almohandes, Kyi Zin Thant, Sofia Gill, Dayna Gill, Hayley Forsdick, Alan J Sinclair, Muhammad Ali Karamat, Srikanth Bellary
Glycaemic outcomes in people living with diabetes under 65 and over 65 years old using an intermittently scanned continuous glucose monitoring system. Therapeutic advances in endocrinology and metabolism 15 (2024)
Ayla Evins, Jill Mayhew, Tricia Cimms, Julie Whyte, Kathy Vong, Elizabeth Hribal, Christopher J Evans, Andrew Grimm
Glycogen storage disease type III: a mixed-methods study to assess the burden of disease. Therapeutic advances in endocrinology and metabolism 15 (2024)
Dongxiao Zhang, Chen Li, Wenchao Hu, Lanjie He
ANDROID and A/G ratio are correlated with sarcopenia among type 2 diabetes patients. Therapeutic advances in endocrinology and metabolism 15 (2024)
Sharmaine Thirunavukarasu, Mehak Asad, Sindhoora Kotha, Henry Procter, Marilena Giannoudi, Hui Xue, Peter Kellman, John P Greenwood, Eylem Levelt
Remote myocardial zone characteristics in type 2 diabetes patients with prior myocardial infarction and comparisons with diabetes patients with no prior infarction. Therapeutic advances in endocrinology and metabolism 15 (2024)
Dongxiao Zhang, Chen Li, Wenchao Hu, Lanjie He
ANDROID and A/G ratio are correlated with sarcopenia among type 2 diabetes patients. Therapeutic advances in endocrinology and metabolism 15 (2024)
Davis Kibirige, Isaac Sekitoleko, William Lumu, Nihal Thomas, Meredith Hawkins, Angus G Jones, Andrew T Hattersley, Liam Smeeth, Moffat J Nyirenda
Phenotypic characterization of nonautoimmune diabetes in adult Ugandans with low body mass index. Therapeutic advances in endocrinology and metabolism 15 (2024)
Tamer Mohamed Elsherbiny
Quitting smoking as a probable trigger for new-onset hypothyroidism after successful medical treatment of Graves' disease: case report. Therapeutic advances in endocrinology and metabolism 15 (2024)
Larissa Fabre, Érika Bevillaqua Rangel
Age-related markers and predictors of diabetic kidney disease progression in type 2 diabetes patients: a retrospective cohort study. Therapeutic advances in endocrinology and metabolism 15 (2024)
Larissa Fabre, Érika Bevillaqua Rangel
Age-related markers and predictors of diabetic kidney disease progression in type 2 diabetes patients: a retrospective cohort study. Therapeutic advances in endocrinology and metabolism 15 (2024)
Ritah Kiconco, Sylvia Achieng Lumumba, Charles Nkubi Bagenda, Raymond Atwine, Joseph Ndarubweine, Simon Peter Rugera
Insulin therapy among diabetic patients in rural communities of Sub-Saharan Africa: a perspective review. Therapeutic advances in endocrinology and metabolism 15 (2024)
Riemer A Been, Annel Lameijer, Reinold O B Gans, André P van Beek, Andrew P Kingsnorth, Pratik Choudhary, Peter Ruben van Dijk
The impact of socioeconomic factors, social determinants, and ethnicity on the utilization of glucose sensor technology among persons with diabetes mellitus: a narrative review. Therapeutic advances in endocrinology and metabolism 15 (2024)
Consolato Maria Sergi, Mohit Kehar, Carolina Jimenez-Rivera
Liver Biopsy Handling of Metabolic-Associated Fatty Liver Disease (MAFLD): the Children's Hospital of Eastern Ontario grossing protocol. Therapeutic advances in endocrinology and metabolism 15 (2024)
Sindhoora Kotha, Sven Plein, John P Greenwood, Eylem Levelt
Role of epicardial adipose tissue in diabetic cardiomyopathy through the lens of cardiovascular magnetic resonance imaging - a narrative review. Therapeutic advances in endocrinology and metabolism 15 (2024)
Mona Mohamed Ibrahim Abdalla
Therapeutic potential of adiponectin in prediabetes: strategies, challenges, and future directions. Therapeutic advances in endocrinology and metabolism 15 (2024)
Mona Mohamed Ibrahim Abdalla
Therapeutic potential of adiponectin in prediabetes: strategies, challenges, and future directions. Therapeutic advances in endocrinology and metabolism 15 (2024)
Carol Wong, Anne De Bray, Naeem Ul Hassan, Ahmed Almohandes, Kyi Zin Thant, Sofia Gill, Dayna Gill, Hayley Forsdick, Alan J Sinclair, Muhammad Ali Karamat, Srikanth Bellary
Glycaemic outcomes in people living with diabetes under 65 and over 65 years old using an intermittently scanned continuous glucose monitoring system. Therapeutic advances in endocrinology and metabolism 15 (2024)
Patrick Ashinze, Toufik Abdul-Rahman, Andrew Awuah Wireko
Semaglutide in the spotlight: weighing benefits against rising concerns. Therapeutic advances in endocrinology and metabolism 15 (2024)
Hareer Fatima, Hussain Sohail Rangwala, Muhammad Saqlain Mustafa, Muhammad Ashir Shafique, Syed Raza Abbas, Burhanuddin Sohail Rangwala
Analyzing and evaluating the prevalence and metabolic profile of lean NAFLD compared to obese NAFLD: a systemic review and meta-analysis. Therapeutic advances in endocrinology and metabolism 15 (2024)
Clifford J Bailey
Diabetes and gout: another role for SGLT2 inhibitors? Therapeutic advances in endocrinology and metabolism 15 (2024)
Tingfen Han, Wenli Chen, Xiasang Qiu, Weijie Wang
Epidemiology of gout - Global burden of disease research from 1990 to 2019 and future trend predictions. Therapeutic advances in endocrinology and metabolism 15 (2024)
Lirong Lin, Xianfeng Pan, Yuanjun Feng, Jurong Yang
Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor. Therapeutic advances in endocrinology and metabolism 15 (2024)
Lirong Lin, Xianfeng Pan, Yuanjun Feng, Jurong Yang
Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor. Therapeutic advances in endocrinology and metabolism 15 (2024)
Ana María Gómez Medina, Camilo A González, Oscar M Muñoz, Yalinne Gómez, Pablo E Jaramillo, Diana Henao, Luis M Rodríguez, Yurany Molina
HbA1c overestimates the glucose management indicator: a pilot study in patients with diabetes, chronic kidney disease not on dialysis, and anemia using isCGM. Therapeutic advances in endocrinology and metabolism 15 (2024)
Tingfen Han, Wenli Chen, Xiasang Qiu, Weijie Wang
Epidemiology of gout - Global burden of disease research from 1990 to 2019 and future trend predictions. Therapeutic advances in endocrinology and metabolism 15 (2024)
Mohammed Eslam, Maryam Al Khatry, Ming-Lung Yu, Ashok Choudhury, Giada Sebastiani, Saleh A Alqahtani, Mohammed Eslam
MAFLD: an ideal framework for understanding disease phenotype in individuals of normal weight. Therapeutic advances in endocrinology and metabolism 15 (2024)
Tamer Mohamed Elsherbiny
Quitting smoking as a probable trigger for new-onset hypothyroidism after successful medical treatment of Graves' disease: case report. Therapeutic advances in endocrinology and metabolism 15 (2024)
Harold Henrison Chang Chiu, Jun-Sing Wang
Potential of duodenal mucosal resurfacing in achieving glycemic control in Asians with type 2 diabetes. Therapeutic advances in endocrinology and metabolism 15 (2024)
Davis Kibirige, Isaac Sekitoleko, William Lumu, Nihal Thomas, Meredith Hawkins, Angus G Jones, Andrew T Hattersley, Liam Smeeth, Moffat J Nyirenda
Phenotypic characterization of nonautoimmune diabetes in adult Ugandans with low body mass index. Therapeutic advances in endocrinology and metabolism 15 (2024)
Waleed Alghamdi, Mahmoud Mosli, Saleh A Alqahthani
Gut microbiota in MAFLD: therapeutic and diagnostic implications. Therapeutic advances in endocrinology and metabolism 15 (2024)
Waleed Alghamdi, Mahmoud Mosli, Saleh A Alqahthani
Gut microbiota in MAFLD: therapeutic and diagnostic implications. Therapeutic advances in endocrinology and metabolism 15 (2024)
Mohammed Eslam, Maryam Al Khatry, Ming-Lung Yu, Ashok Choudhury, Giada Sebastiani, Saleh A Alqahtani, Mohammed Eslam
MAFLD: an ideal framework for understanding disease phenotype in individuals of normal weight. Therapeutic advances in endocrinology and metabolism 15 (2024)
Riemer A Been, Annel Lameijer, Reinold O B Gans, André P van Beek, Andrew P Kingsnorth, Pratik Choudhary, Peter Ruben van Dijk
The impact of socioeconomic factors, social determinants, and ethnicity on the utilization of glucose sensor technology among persons with diabetes mellitus: a narrative review. Therapeutic advances in endocrinology and metabolism 15 (2024)
Saleh Hadi Alharbi
Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications. Therapeutic advances in endocrinology and metabolism 15 (2024)
Ayla Evins, Jill Mayhew, Tricia Cimms, Julie Whyte, Kathy Vong, Elizabeth Hribal, Christopher J Evans, Andrew Grimm
Glycogen storage disease type III: a mixed-methods study to assess the burden of disease. Therapeutic advances in endocrinology and metabolism 15 (2024)
Patrick Ashinze, Toufik Abdul-Rahman, Andrew Awuah Wireko
Semaglutide in the spotlight: weighing benefits against rising concerns. Therapeutic advances in endocrinology and metabolism 15 (2024)

volume 14, 2023

Trupti Nagendra Prasad, Sanjay Kumar Bhadada, Veenu Singla, Neelam Aggarwal, Sant Ram, Uttam Chand Saini, Ashok Kumar, Rimesh Pal
Efficacy of zoledronate, denosumab or teriparatide in postmenopausal women with type 2 diabetes mellitus at high risk of fragility fractures: protocol of an open, blinded endpoint randomized controlled pilot trial. Therapeutic advances in endocrinology and metabolism 14 (2023)
Li-Hsin Chang, Chia-Huei Chu, Chin-Chou Huang, Liang-Yu Lin
Soluble tumor necrosis factor receptor type 1 predicts cardiorenal outcomes and better associated with distinct cardiovascular or renal outcomes than precedential renal or cardiovascular events in type 2 diabetes mellitus. Therapeutic advances in endocrinology and metabolism 14 (2023)
Lavanya Athithan, Gaurav S Gulsin, Joseph Henson, Loai Althagafi, Emma Redman, Stavroula Argyridou, Kelly S Parke, Jian L Yeo, Thomas Yates, Kamlesh Khunti, Melanie J Davies, Gerry P McCann, Emer M Brady
Response to a low-energy meal replacement plan on glycometabolic profile and reverse cardiac remodelling in type 2 diabetes: a comparison between South Asians and White Europeans. Therapeutic advances in endocrinology and metabolism 14 (2023)
Ploutarchos Tzoulis, Maria P Yavropoulou
Association of hyponatremia with bone mineral density and fractures: a narrative review. Therapeutic advances in endocrinology and metabolism 14 (2023)
Steven Rella, Joseph Onyiah, Chelsea Baker, Vatsala Singh, Andrew Her, Neda Rasouli
Design and rationale for the SIB trial: a randomized parallel comparison of semaglutide versus placebo on intestinal barrier function in type 2 diabetes mellitus. Therapeutic advances in endocrinology and metabolism 14 (2023)